Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2007-07-17
2007-07-17
Lambkin, Deborah C. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S448000, C514S443000, C514S378000, C514S336000, C514S456000, C560S009000, C549S051000, C549S070000, C549S399000, C548S247000, C546S282700
Reexamination Certificate
active
10774260
ABSTRACT:
This invention relates to compounds that alter PPAR activity. The invention also relates to pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods of using them as therapeutic agents for treating or preventing dyslipidemia, hypercholesterolemia, obesity, hyperglycemia, atherosclerosis, hypertriglyceridemia and hyperinsulinemia in a mammal. The present invention also relates to methods for making the disclosed compounds.
REFERENCES:
patent: 6699904 (2004-03-01), Hayward et al.
patent: 6723740 (2004-04-01), Chao et al.
patent: 6787552 (2004-09-01), Sakuma et al.
patent: 6867224 (2005-03-01), Cheng et al.
patent: 6964983 (2005-11-01), Auerbach et al.
patent: 6987118 (2006-01-01), Chang
patent: 7005440 (2006-02-01), Jayyosi et al.
patent: 2003/0207915 (2003-11-01), Cheng et al.
patent: 2003/0207924 (2003-11-01), Cheng et al.
patent: 2003/0225158 (2003-12-01), Auerbach et al.
patent: 0028063 (2000-08-01), None
patent: 0930299 (2003-09-01), None
patent: 2058785 (2000-05-01), None
patent: WO 97/28137 (1997-10-01), None
patent: WO 97/28149 (1997-10-01), None
patent: WO 01/00603 (2001-06-01), None
patent: WO 01/16120 (2001-10-01), None
patent: WO 02/16331 (2002-03-01), None
patent: WO 02/50047 (2002-05-01), None
patent: WO 02/50048 (2002-05-01), None
patent: WO 02/100403 (2002-05-01), None
patent: WO02/50047 (2002-06-01), None
patent: WO 02/062774 (2002-06-01), None
patent: WO 02/092590 (2002-09-01), None
patent: WO 02/096904 (2002-09-01), None
patent: WO02/18355 (2002-10-01), None
patent: WO 02/102780 (2002-10-01), None
patent: WO 03/011842 (2003-01-01), None
patent: WO 03/024395 (2003-02-01), None
patent: WO 2004/000315 (2004-03-01), None
patent: WO 2004/000762 (2004-07-01), None
patent: WO 2004/000785 (2004-07-01), None
G. Romussi et al., Spectral Properties of Mono- and Dihydroxychromones, J Heterocyclic Chem vol. 13, p. 211 (1976).
T. Gordon et al., High Density Lipoprotein As A Protective Factor Against Coronary Heart Disease, The American Journal of Medicine, vol. 62, May 1977 707-714.
W.R. Oliver et al., A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport, PNAS, vol. 98 No. 9 5306-5311, 1998.
Bratton Larry D.
Cheng Xue-Min
Erasga Noe
Filzen Gary F.
Geyer Andrew G.
Ashbrook Charles W.
Ganjeizadeh Mehdi
Lambkin Deborah C.
Sherwood Michelle
Warner Lambert Company LLC
LandOfFree
Compounds that modulate PPAR activity and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds that modulate PPAR activity and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds that modulate PPAR activity and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3790375